Podcasts about Perioperative

Listen as we discuss the highly-awaited ESOPEC trial, which examines treatment regimens for esophageal and EGJ adenocarcinoma. Wildly impress your thoracic attendings or peers with your nuanced knowledge! FLOT who? You'll know. Pull out the paper and listen along! Learning Objectives: -Discuss the patient population in the ESOPEC trial -Discuss the main differences between the ESOPEC trial and the CROSS trial -Describe the main drawbacks between FLOT and the CROSS regimen. Hosts: Chloe Hanson MD, Brian Louie MD, and Peter White MD   Referenced Material https://www.nejm.org/doi/full/10.1056/NEJMoa2409408 Hoeppner J, Brunner T, Schmoor C, Bronsert P, Kulemann B, Claus R, Utzolino S, Izbicki JR, Gockel I, Gerdes B, Ghadimi M, Reichert B, Lock JF, Bruns C, Reitsamer E, Schmeding M, Benedix F, Keck T, Folprecht G, Thuss-Patience P, Neumann UP, Pascher A, Imhof D, Daum S, Strieder T, Krautz C, Zimmermann S, Werner J, Mahlberg R, Illerhaus G, Grimminger P, Lordick F. Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer. N Engl J Med. 2025 Jan 23;392(4):323-335. doi: 10.1056/NEJMoa2409408. PMID: 39842010. https://www.nejm.org/doi/full/10.1056/NEJMoa1112088 van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, Richel DJ, Nieuwenhuijzen GA, Hospers GA, Bonenkamp JJ, Cuesta MA, Blaisse RJ, Busch OR, ten Kate FJ, Creemers GJ, Punt CJ, Plukker JT, Verheul HM, Spillenaar Bilgen EJ, van Dekken H, van der Sangen MJ, Rozema T, Biermann K, Beukema JC, Piet AH, van Rij CM, Reinders JG, Tilanus HW, van der Gaast A; CROSS Group. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012 May 31;366(22):2074-84. doi: 10.1056/NEJMoa1112088. PMID: 22646630. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)32557-1/abstract Al-Batran SE, Homann N, Pauligk C, Goetze TO, Meiler J, Kasper S, Kopp HG, Mayer F, Haag GM, Luley K, Lindig U, Schmiegel W, Pohl M, Stoehlmacher J, Folprecht G, Probst S, Prasnikar N, Fischbach W, Mahlberg R, Trojan J, Koenigsmann M, Martens UM, Thuss-Patience P, Egger M, Block A, Heinemann V, Illerhaus G, Moehler M, Schenk M, Kullmann F, Behringer DM, Heike M, Pink D, Teschendorf C, Löhr C, Bernhard H, Schuch G, Rethwisch V, von Weikersthal LF, Hartmann JT, Kneba M, Daum S, Schulmann K, Weniger J, Belle S, Gaiser T, Oduncu FS, Güntner M, Hozaeel W, Reichart A, Jäger E, Kraus T, Mönig S, Bechstein WO, Schuler M, Schmalenberg H, Hofheinz RD; FLOT4-AIO Investigators. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet. 2019 May 11;393(10184):1948-1957. doi: 10.1016/S0140-6736(18)32557-1. Epub 2019 Apr 11. PMID: 30982686. ***Fellowship Application Link: https://forms.gle/PQgAvGjHrYUqAqTJ9 Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more. If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

In this episode, Dr. Sergion Zanotti discusses TEE in cardiac arrest and shock. Critical care clinicians commonly utilize transthoracic echocardiography in the ICU as part of their point-of-care-ultrasonography (POCUS) toolkit. However, there is a growing push to train intensivists in using transesophageal echocardiography (TEE) for cardiac arrest and peri-arrest situations in the ICU. Our guest is Dr. Sara Nikravan, a cardiothoracic anesthesia critical care physician with training in advanced perioperative echocardiography. Dr. Nikravan is an Associate Professor of Cardiothoracic Anesthesiology and Critical Care Medicine at the University of Washington Medical School and practices at the UW Medical Center. She is recognized as an expert and master educator in Critical Care, Perioperative echocardiography, and Point of Care Ultrasound. She has authored numerous peer-reviewed papers and is the guidelines co-chair of the Society of Critical Care Medicine Guidelines on Adult Critical Care Ultrasonography: Focused Update 2024, recently published in Critical Care Medicine.  Additional links: Society of Critical Care Medicine Guidelines on Adult Critical Care Ultrasonography: Focused Update 2024, Crit Care Med 2025: https://pubmed.ncbi.nlm.nih.gov/39982182/ Focused Transesophageal Echocardiography During Cardiac Arrest Resuscitation: JACC Review Topic of the Week. JACC 2020: https://pubmed.ncbi.nlm.nih.gov/32762909/ Landing page for the Resuscitative TEE Project website: https://www.resuscitativetee.com/ Books mentioned in this episode: The Prophet. By Kahlil Gibran: https://www.amazon.com/dp/998247037X?psc=1&smid=ATVPDKIKX0DER&ref_=chk_typ_imgToDp

This week, we discuss another set of high yield topic for anyone who cares for patients on anticoagulation - how to safely hold anticoagulation prior to a procedure and how to reverse the effects of the drug in the even of an emergent situation. We discuss our approach to how we discuss this with our patients and our medical colleagues! Dan also shares his dotphrases for your reference! Episode contents:- How do we approach peri-operative anticoagulation management? When do we hold? How long do we hold? Do they need bridging? No bridging? - In the case of a severe bleed, how do we reverse the effects of anticoagulation?**** Get paid to participate in market research surveys: https://affiliatepanel.members-only.online/FOC_24?utm_campaign=FOC&utm_source=email&utm_medium=email** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodesLove what you hear? Tell a friend and leave a review on our podcast streaming platforms!Twitter: @TheFellowOnCallInstagram: @TheFellowOnCallListen in on: Apple Podcast, Spotify, and Google Podcast

IBD Drive Time: Perioperative Optimization in IBD by Gastroenterology Learning Network

Medication safety remains a cornerstone of anesthesia practice with complex environments and high-stakes decisions requiring vigilant attention to prevent errors. This collaboration between APSF and OpenAnesthesia spotlights critical aspects of perioperative drug safety with practical insights from Dr. Juan Li, a cardiothoracic anesthesia fellow at Beth Israel Deaconess Medical Center.• Perioperative anaphylaxis requires immediate recognition of cardiovascular, respiratory, and cutaneous manifestations• Neuromuscular blocking agents and antibiotics represent common triggers for anaphylactic reactions• Preoperative assessment must include thorough allergy history, medication reconciliation, and identification of drug-drug interactions• Standardized drug concentrations, preparation methods, and equipment minimize medication errors• Technology integration through barcode readers and computerized decision support enhances safety• Pharmacy support with pre-mixed solutions and pre-filled syringes reduces preparation errors• Post-operative monitoring remains critical for catching delayed medication reactions• Safety culture should emphasize root cause analysis rather than punishment for medication errors• Implementation of standard protocols is essential for managing new medications with limited safety dataVisit APSF.org and Openanesthesia.org for detailed information and resources on medication safety in anesthesia practice.

Sharpen your approach to high-risk renal cell carcinoma (RCC). In this episode of BackTable Urology, guest Dr. Sumanta (Monty) Pal from City of Hope joins host Dr. Aditya Bagrodia to discuss contemporary kidney cancer treatment and the complexities of perioperative therapy. --- This podcast is supported by: Photocure https://www.photocure.com/ --- SYNPOSIS The conversation covers the challenging side effects of perioperative treatments, the evolution of therapies from tyrosine kinase inhibitors to modern checkpoint inhibitors, and the introduction of adjuvant therapies. Dr. Pal and Dr. Bagrodia explore the impact of these treatments on patient outcomes, the challenges with current biomarkers, and the potential of emerging trials. The doctors also highlight the importance of personalized RCC management strategies, particularly for high-risk patients and non-clear cell histologies. They also emphasize the need for appropriate patient counseling in this emerging field. --- TIMESTAMPS 00:00 - Introduction 01:53 - Evolution of Kidney Cancer Treatments 03:30 - Tyrosine Kinase Inhibitors in the 2010s 10:42 - Checkpoint Inhibitor Trials 23:09 - Discussing Adjuvant Therapy with Patients 26:56 - Restaging and Biomarkers 31:58 - Challenges in Adjuvant Immunotherapy 39:57 - Non-Clear Cell RCC 41:42 - Future Directions --- RESOURCES Photocure: https://www.photocure.com/

2024 ACC/AHA guideline update, including biomarker testing, MINS, and other consulting tips Master perioperative medicine! Learn when to hold ACE inhibitors, how to manage OSA without delaying surgery, and why "NPO after midnight" is outdated. We're joined by Dr. Avital O'Glasser, our Chief of Perioperative Medicine! Claim CME for this episode at curbsiders.vcuhealth.org! Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CME Show Segments Intro Case Preoperative Assessment & Consulting Tips Risk Calculators Frailty Pulmonary Considerations Cardiovascular Meds & BP Management NPO: Why Are We Still Doing This? Biomarkers & Postoperative Risk MINS Outro Credits Written and produced, show notes, cover art, CME, and infographics: Paul Wurtz MD.  Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP Reviewer: Molly Heublein MD Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Technical Production: PodPaste Guest: Avital O'Glasser MD Disclosures Dr. O'Glasser reports no relevant financial disclosures. The Curbsiders report no relevant financial disclosures.  Sponsor: EZResus  Listeners of the Cribsiders and Curbsiders podcasts get access to a 2-month free trial,letting them use 100% of the features of the  For more information, www.ezresus.com/curbsiders and Use promo code Curbsiders Sponsor: Freed Visit Freed.ai and Usecode:CURB50 to get $50 off your first month when you subscribe. Sponsor: Mint Mobile Get 3 months of premium wireless service from Mint Mobile for $15 a month.Shop plans at mintmobile.com/curb

Drs. Muhammad Rafique and Igor Tkachenko, guest editors of the April ASA Monitor, discuss the road to and from the perioperative experience with Dr. Zach Deutch. Learn about the history of perioperative medicine, the role of anesthesiologists beyond the OR and around the globe, and more. Recorded February 2025. 

In this episode of MedNews Week's Oncology Unplugged, host Chandler Park, MD, a medical oncologist at Norton Cancer Institute in Louisville, Kentucky, spoke with Petros Grivas, MD, PhD, clinical director of the Genitourinary Cancers Program at Fred Hutchinson Cancer Center and a professor of medicine at the University of Washington School of Medicine, about key updates from the 2025 Genitourinary Cancers Symposium and the evolving treatment paradigm for muscle-invasive bladder cancer (MIBC).

"Enhancing Patient-Physician Interactions: Addressing Barriers and Strengthening Relationships in the Perioperative Setting." From ASRA Pain Medicine News, February 2025. See the original article at www.asra.com/february25news for figures and references. This material is copyrighted. Support the show

Season 14 is a wrap! And while we wait for Season 15, we're bringing you an audio version of an  interview we did with Stella Yau during Perioperative Nurses Week! In this interview, we're talking with Stella Yau about her experience as a perioperative nurse in the US Navy. As she tells her story, you'll hear about nursing school education in the United States, about the additional responsibilities for nursing students in an ROTC Program, you'll learn what it was like for her as nurse serving in the Navy, and how she has used her experiences to influence her career now as a civilian perioperative nurse. 

Editor in Chief Cecelia E. Schmalbach, MD, MSc, is joined by senior author Gresham T. Richter MD, and Associate Editor John P. Dahl, MD, PhD, MBA, to discuss the outcomes of not admitting pediatric supraglottoplasty patients as outlined in the paper “Is Outpatient Supraglottoplasty Possible? Examination of Perioperative Comorbidities and Outcomes” which published in the March 2025 issue of Otolaryngology–Head and Neck Surgery. They talk about the necessity of keeping patients at the hospital for different comorbidities and situations, Click here to read the full article.

Recorded at Evidence Based Perioperative Medicine (EBPOM) in London last year this presentation is part of a series of talks given under the session heading: “Implementation – what works and what doesn't?”. This piece is part one of four, with two more presentations to come and then a fascinating panel discussion to conclude. This first session focuses on the implementation of clinical trials, covering research methodologies, clinical implementations, and their challenges, and looking at the lengthy process of translating medical discoveries into clinical practice, emphasizing the ethical obligation to disseminate trial results effectively. The under-representation of certain demographics in trials, the gap between research findings and clinical practice, and the need for better communication strategies is stressed alongside solutions, including training for researchers, involving key stakeholders from the start, and the role of funders in supporting effective dissemination and implementation of research findings. Our presenter is, Joyce Yeung, Professor of Anaesthesia and Critical Care Medicine at the University of Warwick. She is Theme Lead of the Emergency, Prehospital, Perioperative and Critical Care Trials group within Warwick Clinical Trials Unit. Clinically she holds appointments as a Consultant in Critical Care Medicine at University Hospital Birmingham NHS Foundation Trust. Joyce is Director of UK Perioperative Medicine Clinical Trials Network. She is joint Clinical Speciality Lead for Anaesthesia, Perioperative Medicine and Pain for West Midlands Comprehensive Research Network. She is also the Chair of Resuscitation Council UK Immediate Life Support Subcommittee and is a member of Scientific and Education Committee at European Resuscitation Council. She serves as expert systematic reviewer and International Liaison Committee on Resuscitation taskforce member. Joyce is Chief Investigator for a major grant examining the impact of volatile versus intravenous anaesthesia in non-cardiac surgery (VITAL trial). Her research interests are applied health research and clinical trials including improving perioperative patient outcomes, chronic pain, post-operative cognitive dysfunction, and resuscitation. For more information about EBPOM and the conferences they are organising this year please go to www.ebpom.org

Tobacco use is a known modifiable risk factor for postoperative complications and revision surgery after anterior cruciate ligament reconstruction (ACLR). Previous studies focus on tobacco as a broad categorization of traditional smoking, smokeless tobacco, and other forms of nicotine use. It is unclear if differences in the type of nicotine used lead to similar adverse outcomes after ACLR.   In conclusion, smokeless tobacco use was associated with an increased risk of medical complications, ED utilization, and subsequent procedures compared with nonuser controls and traditional smokers. These findings highlight the importance of considering specific forms of tobacco use in preoperative screening for patients undergoing ACLR.     Click here to read the article.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/HKW865. CME credit will be available until January 31, 2026.Finding the Heat in Cold Tumours: Potential for Perioperative Immunotherapy Strategies in Early Breast Cancer In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/HKW865. CME credit will be available until January 31, 2026.Finding the Heat in Cold Tumours: Potential for Perioperative Immunotherapy Strategies in Early Breast Cancer In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/HKW865. CME credit will be available until January 31, 2026.Finding the Heat in Cold Tumours: Potential for Perioperative Immunotherapy Strategies in Early Breast Cancer In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/HKW865. CME credit will be available until January 31, 2026.Finding the Heat in Cold Tumours: Potential for Perioperative Immunotherapy Strategies in Early Breast Cancer In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/HKW865. CME credit will be available until January 31, 2026.Finding the Heat in Cold Tumours: Potential for Perioperative Immunotherapy Strategies in Early Breast Cancer In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/HKW865. CME credit will be available until January 31, 2026.Finding the Heat in Cold Tumours: Potential for Perioperative Immunotherapy Strategies in Early Breast Cancer In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/HKW865. CME credit will be available until January 31, 2026.Finding the Heat in Cold Tumours: Potential for Perioperative Immunotherapy Strategies in Early Breast Cancer In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/HKW865. CME credit will be available until January 31, 2026.Finding the Heat in Cold Tumours: Potential for Perioperative Immunotherapy Strategies in Early Breast Cancer In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc.Disclosure information is available at the beginning of the video presentation.

This is the first of a two part program which covers some of the most listened to pieces we've done in the last 12 months. If you want to follow up on these conversations and get the full detail, for free, follow these links here: "Cardiovascular risk evaluation for non-cardiac surgery, guidelines" - https://topmedtalk.libsyn.com/cardiovascular-risk-evaluation-for-non-cardiac-surgery-guidelines-ebpom-24 ”Should we delay surgery for prehabilitation?” - https://topmedtalk.libsyn.com/should-we-delay-surgery-for-prehabilitation-prehabilitation-world-congress ”The importance of intraoperative hypotension” - https://topmedtalk.libsyn.com/the-importance-of-intraoperative-hypotension-aana-2024 “Behavioural change vs Psychological interventions: which is key in prehabilitation?” - https://topmedtalk.libsyn.com/behavioural-change-vs-psychological-interventions-which-is-key-in-prehabilitation-prehabilitation-world-congress "Perioperative patient safety and post-operative ward monitoring" - https://topmedtalk.libsyn.com/perioperative-patient-safety-and-post-operative-ward-monitoring-topmedtalk

We're back, after a brief hiatus! Today we talk about duration of therapy for bacteremia, Factor XI inhibition for atrial fibrillation, whether to stop ACEi or ARB before elective surgery, and whether GLP-1 agonists are beneficial in heart failure with preserved ejection fraction. Go to minute 7:30 to skip the banter. 7 vs 14 Days of Antibiotics for Bacteremia (BALANCE)Abelacimab vs Rivaroxaban for Atrial Fibrillation (AZALEA-TIMI-71)Asenduxian vs Apixaban for Atrial Fibrillation (OCEANIC-AF)ACEi or ARB Discontinuation Before Surgery (STOP or NOT)Tirzepatide for HFpEF and Obesity (SUMMIT)Music from Uppbeat (free for Creators!):https://uppbeat.io/t/soundroll/dopeLicense code: NP8HLP5WKGKXFW2R

This episode, recorded live at the Becker's Healthcare 12th Annual CEO + CFO Roundtable features Ruben Azocar, VP for Perioperative Services at Beth Israel Deaconess Medical Center. Here, he shares his perspectives on addressing cybersecurity risks, leveraging artificial intelligence for operational efficiency, and tackling financial challenges in healthcare. He discusses strategies for improving patient care while managing costs, and how AI can support the revenue cycle and enhance the use of operating rooms.In collaboration with R1.

Welcome back Rounds Table Listeners!We are back today with our Classic Rapid Fire Podcast!This week, Drs. Mike and John Fralick discuss two recent papers - whether aspirin should be held in patients with stable coronary artery disease and drug-eluting stents and the role of semaglutide in patients with obesity and knee osteoarthritis. Two papers, here we go!Aspirin Monotherapy vs. No Antiplatelet Therapy in Stable Patients With Coronary Stents Undergoing Low-to-Intermediate Risk Noncardiac Surgery (0:00 – 10:15).Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis (10:15 – 22:50).And for the Good Stuff:"I'm making money from my terrible paintings" (22:50 – 23:25).Squid Game Season Two (23:25 – 24:43)Questions? Comments? Feedback? We'd love to hear from you! @roundstable @InternAtWork @MedicinePods

Emergence, Transmission, and Containment of Candida auris in the Perioperative Setting by AORNJournal

Supporting Ethical Competence in Perioperative Nursing by AORNJournal

Moderator: James P. Rathmell, M.D. Participants: James Hitt, M.D., Ph.D. and Mark C Bicket, M.D., Ph.D. Articles Discussed: Continuation versus Interruption of Buprenorphine/Naloxone in Adult Veterans Undergoing Surgery: Examination of Postoperative Pain and Opioid Utilization in a National Retrospective Cohort Study Building a Better Base for Keeping Buprenorphine on Board for Surgery Transcript

Host: Darryl S. Chutka, M.D. Guest: Chris R. Stephenson, M.D., M.H.P.E. Some patients about to have a surgical procedure will have a preoperative assessment completed by the anesthesiologist on the day of the surgery. However, in many cases, patients are having an evaluation at a perioperative clinic, well prior to their procedure. Although this results in an additional visit for the patient, there are advantages to this approach. Benefits include improvements in hospital efficiency, cost savings from shorter hospital stays and more appropriate use of laboratory tests. So, what does a perioperative assessment consist of? Do they assist the surgeon in their postoperative management of the patient, and does it result in better clinical outcomes? This podcast will address the perioperative medical assessment, and these are some of the questions I'll be asking my guest, Chris R. Stephenson, M.D., M.H.P.E., from the Division of General Internal Medicine at the Mayo Clinic. Connect with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development 

Are you looking to deepen your understanding of perioperative medication? Join us for the first episode of 2025, where we offer listeners an author insight into the recently published ‘2024 EACTS Guidelines on perioperative medication in adult cardiac surgery'. With working group members Anders Jeppsson and Emma Hansson, our host Miia L Lehtinen explores the fundamental intricacies considered to ensure these diverse guidelines are current and clinically applicable. Discussions include how the varied specialities of clinical intervention contribute to individual patient needs, including indication specific medication schedules, and the nuanced effects these bring to patients. We also encourage our listeners to view the recently published perioperative guidelines here: https://academic.oup.com/ejcts/advance-article/doi/10.1093/ejcts/ezae355/7815986?searchresult=1&login=false

DISCLAMER >>>>>>    The Ditch Lab Coat podcast serves solely for general informational purposes and does not serve as a substitute for professional medical services such as medicine or nursing. It does not establish a doctor/patient relationship, and the use of information from the podcast or linked materials is at the user's own risk. The content does not aim to replace professional medical advice, diagnosis, or treatment, and users should promptly seek guidance from healthcare professionals for any medical conditions.   >>>>>> The expressed opinions belong solely to the hosts and guests, and they do not necessarily reflect the views or opinions of the Hospitals, Clinics, Universities, or any other organization associated with the host or guests.       Disclosures: Ditch The Lab Coat podcast is produced by (Podkind.co) and is independent of Dr. Bonta's teaching and research roles at McMaster University, Temerty Faculty of Medicine and Queens University. Welcome to another episode of "Ditch the Labcoat," the podcast that brings a critical, science-based perspective to healthcare discussions. I'm your host, Dr. Mark Bonta, and today we dive deep into the intersection of nutrition and surgery. Joining us are Dr. Sagar Desai, an orthopedic surgeon, and Dr. Kyle Waldman, an anesthesiologist.We'll explore the influence of pharmaceutical companies in medicine, the importance of non-drug interventions, and how nutritional modifications can offer significant patient benefits. Our focus will be on immuno and pharmaco nutrition—innovative approaches combining amino acids, omega-3s, vitamins, and other nutrients to improve surgical outcomes and patient recovery.Sagar and Kyle will share their entrepreneurial journey with Proven Therapeutics, aiming to provide better perioperative care. We'll discuss the challenges of patient compliance, the evidence supporting these nutritional strategies, and the practicalities of implementing them in both academic and community settings.Plus, for a bit of levity, we'll be addressing some of the common stereotypes in the medical profession and the humorous side of our intense, life-saving work.So, grab your headphones and get ready to ditch the labcoat. Let's jump into a conversation that blends serious science with a touch of humor, all in the pursuit of better healthcare.06:21 - Unexpectedly switched career focus from orthopedics to internal medicine.09:32 - Steroids and diet significantly impact bowel surgery recovery.10:39 - Oral immunonutrition reduces the risk of anastomotic leaks.16:33 - Nutritional changes can outperform medications after heart attacks.17:26 - Nutrition data from general surgery applies to orthopedics as well.22:44 - Challenges and strategies for managing surgical anesthesia effectively.23:53 - Perioperative immunonutrition addresses the surgical stress response.28:12 - Evidence-based nutritional products are underutilized despite proven benefits.32:08 - Healthcare workers are genuinely dedicated to helping patients.37:18 - Thorough research ensures positive feedback on nutritional products.43:52 - Low financial risk, careful work, and significant patient benefits.45:29 - Enjoyable interviews with intellectual, humorous, and influential guests.47:28 - Evidence-based treatments are often overlooked in medical prescriptions.

Preparing a patient for cardiac surgery entails a individualized and coordinated effort to optimize medical therapy while simultaneously minimizing surgical, thrombotic, and bleeding risk. Guest Jane Linderbaum, ARNP, CNP, describes how to help prepare patients and help them understand details such as specific dates to stop taking medications.Related PCNA Professional Development: CVD Diagnostics: Demystifying which, when and why? https://pcna.net/online-course/cvd-diagnostics-demystifying-which-when-and-why/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

While we wait for Season 14, we're bringing you an audio version of our Perioperative Nurses Week video interview series. Catch up on any interview you missed and travel around the world with us!  How would you like to get a post-graduate degree in Perioperative nursing? In Spain, you can! Today we're traveling to Spain to learn more about perioperative nursing and nursing education from Esther Espunes Mestres. Esther has a great story to share with us, so tune in and learn what it's like to train and be an OR nurse in Spain! #operatingroom #ornurse #perioperativenursesweek #nurse #perioperative #perioperative

While we wait for Season 14, we're bringing you an audio version of our Perioperative Nurses Week video interview series. Catch up on any interview you missed and travel around the world with us!  Today we're traveling from S. Africa to California as we learn about perioperative nursing and nursing education from Andrew Veitch. Andrew has a great story to share with us, so tune in and learn what it's like to be a nurse in S. Africa! Andrew will also tell us about the differences he's observed in perioperative nursing after having worked in both S. Africa and the US.  #operatingroom #ornurse #perioperativenursesweek #nurse #perioperative #perioperativenurse

In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a discussion on the FDA approval of perioperative nivolumab based on the Phase III CheckMate 77T study. Perioperative therapy has improved outcomes in patients with resectable NSCLC and is emerging as best practice but there is nuance to the delivery of this therapy. Guest: Dr. Tina Cascone is a Physician-Scientist and Associate Professor in the Department of Thoracic/Head and Neck Medical Oncology at the University of Texas MD Anderson Cancer Center in Houston, Texas and lead author of the CheckMate 77T manuscript in the New England Journal of Medicine Guest: Dr. Shun Lu is the Chief of Shanghai Lung Cancer Center and Shanghai Chest Hospital and Professor at Shanghai Jiaotong University. He is an executive board member of the Chinese Society of Clinical Oncology and past chair of Chinese Lung Cancer Association

Please visit answersincme.com/860/94256783-replay1 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in non–small-cell lung cancer (NSCLC) discuss the rationale and strategies for integrating perioperative immunotherapeutic approaches to resectable NSCLC care plans, and a patient joins the conversation to share her story. Upon completion of this activity, participants should be better able to: Explain the rationale for perioperative immunotherapeutic approaches in the treatment landscape of resectable non-small cell lung cancer (rNSCLC); and Identify when perioperative immunotherapeutic approaches should be considered for patients with rNSCLC.

Season 13 has come to an end, and we're anxiously awaiting the launch of Season 14! While we wait, we're bringing you a series of interviews that we did to celebrate Perioperative Nurses Week.  In this 4-week series, we travelled across the globe to hear from perioperative nurses worldwide. In this first episode, we're speaking with Helen Evans and traveling across the pond to England! We'll learn what nursing education was like for Helen, how much exposure she was given to the OR, and what it was like to work in an operating room in England. We'll also learn about some differences that she observed between England and the United States after she immigrated to the US and began working in the USA. Don't miss this exciting interview and stayed tuned the rest of this month for more! #operatingroom #perioperativenurse #perioperativenurses #ornurse #nurse #surgery

Mitigating Hazards in the Perioperative Setting by AORNJournal

Caring for Patients With Pheochromocytomas in the Perioperative Setting by AORNJournal

On the second November episode of JHLT: The Podcast, the Digital Media Editors continue MCS-month with a paper from the November issue of JHLT, entitled “Aortic insufficiency in the patient on contemporary durable left ventricular assist device support: A state-of-the-art review on perioperative and postoperative assessment and management.”  First author Diyar Saeed, MD, PhD, of the Heart Center Niderrhein, and senior author Jennifer Cowger, MD, MS, of Henry Ford Hospitals both join the podcast. You'll hear about: Why LVAD patients develop new and progressive aortic regurgitation—and how contemporary devices may differ Associated hemodynamic events Intraoperative surgical techniques Slowing the progression of the condition and monitoring it post-op Early interventions For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt. If you haven't yet tuned in for the first November episode of the podcast, MCS enthusiasts will be happy to know the paper discusses temporary MCS devices in acute RV failure. Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.  

In this special crossover episode of Oncology Overdrive, we bring you Healio coverage from the 2024 World Conference on Lung Cancer, as well as Healio's top headlines from the meeting. With insights from Benjamin P. Levy, MD, and top headlines from the conference, Meeting Mic is your on-the-go source for highlights, pearls, and perspectives across all specialties. Benjamin P. Levy, MD, discusses key takeaways from the meeting. 0:49 Read the full coverage here: Ivonescimab extends PFS vs. pembrolizumab in advanced NSCLC, may be ‘a new standard' Source: Zhou C, et al. Abstract 2700. Presented at: IASLC World Conference on Lung Cancer; Sept. 7-10, 2024; San Diego. Perioperative nivolumab improves outcomes in resectable NSCLC Source: Forde PM, et al. Abstract 3589. Presented at: IASLC World Conference on Lung Cancer; Sept. 7-10, 2024; San Diego. Despite progress, barriers to lung cancer biomarker testing persist Source: Smeltzer M, et al. Abstract 3000. Presented at: IASLC World Conference on Lung Cancer; Sept. 7-10, 2024; San Diego. We'd love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Disclosures: Jain reports no relevant financial disclosures. Healio could not confirm relevant financial disclosures for Levy at the time of posting.

How Periop Nurses Create a Culture of Safety (and the Business Case for Why They Make Great Leaders in a Perioperative Setting)Perioperative nurses play a vital role in healthcare, ensuring patient safety and optimizing surgical outcomes. Their dedication to patient advocacy, attention to detail, and ability to foster a culture of collaboration make them invaluable leaders in the operating room (OR).Nurses as Patient AdvocatesAt the heart of perioperative nursing is a deep commitment to patient advocacy. Nurses are the primary advocates for their patients, ensuring their safety and well-being throughout the surgical process. They meticulously monitor patients' vital signs, anticipate potential complications, and communicate effectively with the surgical team to ensure the best possible outcomes.Creating a Culture of SafetyPerioperative nurses are instrumental in creating a culture of safety within the OR. They are meticulous about following protocols, ensuring that all equipment and supplies are sterile, and verifying patient information before procedures. Additionally, nurses actively promote a "speak up" culture, encouraging team members to raise concerns if they notice any potential safety issues.Collaboration and CommunicationEffective communication and collaboration are essential for a safe and efficient OR environment. Perioperative nurses play a key role in facilitating communication among the surgical team, ensuring that everyone is on the same page and that all necessary information is shared. They also act as liaisons between patients and their families, providing updates and addressing concerns.Leadership and InnovationPerioperative nurses often take on leadership roles within the OR, demonstrating their ability to guide and inspire their teams. They are skilled at problem-solving, identifying areas for improvement, and driving innovation. Additionally, nurses are often involved in developing and implementing new protocols and procedures to enhance patient safety and efficiency.Financial Acumen and Business Case for SafetyBeyond their clinical expertise, perioperative nurses can also contribute to the financial health of the organization. By understanding the business aspects of healthcare, nurses can make informed decisions regarding resource allocation and advocate for investments in safety initiatives. They can also quantify the costs associated with safety incidents, demonstrating the financial benefits of prioritizing safety measures.Support the showWelcome to the Periop Talk—your go-to vlog and podcast series where we examine the world of perioperative nursing.Episode after episode, we're bringing you professional tips, clinical wisdom, and personal stories that'll make you feel like you're chatting with your work BFFs. Curious about the latest surgical techniques? We got you. Wondering how to navigate the challenges of the periop journey? We're here for that too.Our vlog and podcast series isn't just about sharing information; it's about building a community. Meet the people behind the masks, hear their journeys, and join the rotation of periop professionals making a difference. From students and new nurses to seasoned pros, we've got content for every stage of your perioperative practice.Periop Talk is your peek behind the red line to the world of perioperative nursing. It's not just about the OR – it's about the heart and soul of healthcare. Let's scrub in and share the periop love!Watch us at: (1) Periop Talk vlog - YouTube

TopMedTalk at Anesthesiology 2024 the annual meeting of the American Society of Anesthesiologists (ASA). Here we delve into how anesthesiologists are paid, the impact of government and commercial payers and recent major issues such as cyberattacks on revenue cycle billing companies. We discuss ongoing advocacy efforts and significant regulatory changes affecting your profession, strategies for managing payment models, and the importance of strong negotiation tactics to maintain viable practices. Presented by Desiree Chappell and Mike Grocott with their guests Lois Connolly, MD, Professor of Anesthesiology at the Medical College of Wisconsin in Milwaukee, WI and ASA Vice President for Professional Affairs and Jonathan Gal, MD, Professor of Anesthesiology, Department of Anesthesiology, Perioperative and Pain Medicine, Icahn School of Medicine at Mount Sinai, System Medical Director- Facility Revenue Integrity & Optimization; System Medical Director- Offsite ASC Anesthesia; ASA Director from New York for the Board of Directors and Chair of the Committee on Economics. Learn more about how The ASA helps you: https://www.asahq.org/advocating-for-you/payment-progress

Success in the operating room is critical to the financial health of many healthcare organizations, with perioperative services contributing up to 75% of primary revenue streams. Effective perioperative care relies on skilled nurses who balance patient care while collaborating with other teams. In this episode of Value-Based Care Insights, Dan Marino sits down with Cindy Mahal, Chief Administrative Officer of Providence Saint Joseph Medical Center, to explore the challenges nurses face in achieving alignment and how to overcome them. We'll uncover insights into key strategies administrators can implement to empower nurses, giving them a voice and enabling them to not only align but also lead.

Ep 114 Cindy Mahal - Perioperative Success Starts with Giving Nurses a Voice at the Table Success in the operating room is critical to the financial health of many healthcare organizations, with perioperative services contributing up to 75% of primary revenue streams. Effective perioperative care relies on skilled nurses who balance patient care while collaborating with other teams. On this episode Dan sits down with Cindy Mahal, Chief Administrative Officer of Providence Saint Joseph Medical Center, to explore the challenges nurses face in achieving alignment and how to overcome them. They'll uncover insights into key strategies administrators can implement to empower nurses, giving them a voice and enabling them to not only align but also lead. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Stay up to date on the latest advancements in gynecologic surgery. In this episode of the BackTable OBGYN Podcast, hosts Dr. Amy Park and Dr. Mark Hoffman invite Dr. Johnny Yi, a pioneer in the field of minimally invasive surgery and urogynecology, to discuss the latest advancements in, benefits of, and challenges with single port robotic gynecologic surgery. --- SYNPOSIS The discussion covers evolutionary strides in robotic-assisted surgeries such as sacral colpopexy and myomectomies, the transition from traditional laparoscopy, and the intricacies of handling large uteri procedures. The episode also navigates the global adoption of these technologies, particularly in South Korea and Japan, and the varying applications in different specialties. Key topics include surgical skill requirements, training needs, innovative techniques, FDA approvals, and the future potential of single port surgeries. Overall, this discussion provides a well-rounded perspective on the current state and forward-looking innovations in the field of gynecologic surgery. --- TIMESTAMPS 00:00 - Introduction 03:57 - Single Port Robotic Surgery 08:27 - Benefits of Robotics with Sacral Colpopexy 11:37 - Technical Aspects of Single Port Surgery 14:40 - Training for Single Port Surgery 19:43 - Global Adoption and Future Potential of Single Port Surgery 25:35 - Access into the Abdomen 29:39 - Challenges and Innovations in Single Port Surgery 31:34 - Evaluating Risks and Success Rates 33:16 - Cost Analysis 35:16 - Training and Simulation for Single Port Surgery 39:35 - Future of Single Port and vNOTES Surgery 45:05 - Patient Reactions and Satisfaction 46:34 - Closing Techniques 52:14 - Future Prospects and Final Thoughts --- RESOURCES Oh S, Yi J, Song AY, Jee J, Bae N, Shin JH. Intraoperative Complications and Perioperative and Surgical Outcomes of Single-Port Robotics-Assisted Sacrocolpopexy. Int Urogynecol J. 2024 Jul; 35 (7):1521-1526 Epub 2024 June 20.

In this episode, Noelle Diesfeld, Vice President of Perioperative Services at HonorHealth, discusses key healthcare trends, including the shift to outpatient services and the impact of AI in optimizing operations. She highlights how AI and robotics are transforming perioperative care and shares insights into HonorHealth's initiatives, such as increasing access to screening colonoscopies and enhancing OR scheduling efficiency.

In this episode, we review key components of the landmark MAGIC and FLOT-4 trials that investigated perioperative chemotherapy in the treatment of locally advanced gastric cancer.  We discuss limitations of both trials and the evolving clinical landscape of gastric cancer treatment. Hosts: - Timothy Vreeland, MD, FACS (@vreelant) is an Associate Professor of Surgery at the Uniformed Services University of the Health Sciences and Surgical Oncologist/HPB surgeon at Brooke Army Medical Center. - Daniel Nelson, DO, FACS (@usarmydoc24) is a Surgical Oncologist/HPB surgeon at Kaiser Permanente Los Angeles Medical Center. - Connor Chick, MD (@connor_chick) is a Surgical Oncology Senior Fellow at Ohio State. - Lexy (Alexandra) Adams, MD, MPH (@lexyadams16) is a Surgical Oncology Junior Fellow at MD Anderson Cancer Center. - Beth (Elizabeth) Barbera, MD (@elizcarpenter16) is a PGY-6 General Surgery resident at Brooke Army Medical Center.  Learning Objectives:  1.     Understand background, methodology, results, and interpretation of the MAGIC trial. 2.     Understand background, methodology, results, and interpretation of the FLOT trial. 3.     Be able to discuss the evolution of chemotherapeutic regimens in the treatment of locally advanced gastric cancer and rationale for their use. 4.     Be able to describe key limitations for the above regimens. 5.     Discuss the the evolving clinical landscape for chemotherapy in gastroesophageal junction tumors. Links to Papers Referenced in this Episode: Journal Articles: Cunningham, D., Allum, W. H., Stenning, S. P., Thompson, J. N., Van de Velde, C. J., Nicolson, M., ... & Chua, Y. J. (2006). Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. New England Journal of Medicine, 355(1), 11-20. https://pubmed.ncbi.nlm.nih.gov/16822992/ Al-Batran, S. E., Homann, N., Pauligk, C., Goetze, T. O., Meiler, J., Kasper, S., ... & Hofheinz, R. D. (2019). Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. The Lancet, 393(10184), 1948-1957. https://pubmed.ncbi.nlm.nih.gov/30982686/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen